How big is the Cell Viability Assays Market?

The Cell Viability Assays Market size is expected to reach USD 1.74 billion in 2024 and grow at a CAGR of 7.70% to reach USD 2.78 billion by 2029. Read More

What is the current Cell Viability Assays Market size?

In 2024, the Cell Viability Assays Market size is expected to reach USD 1.74 billion. Read More

Who are the key players in Cell Viability Assays Market?

Thermo Fischer Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Becton Dickinson & Company and Abcam PLC are the major companies operating in the Cell Viability Assays Market. Read More

Which is the fastest growing region in Cell Viability Assays Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Cell Viability Assays Market?

In 2024, the North America accounts for the largest market share in Cell Viability Assays Market. Read More

What years does this Cell Viability Assays Market cover, and what was the market size in 2023?

In 2023, the Cell Viability Assays Market size was estimated at USD 1.61 billion. The report covers the Cell Viability Assays Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Cell Viability Assays Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Cell Viability Assays Market Share

Statistics for the 2023 & 2024 Cell Viability Assays market share, created by Mordor Intelligence™ Industry Reports. Cell Viability Assays share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Cell Viability Assays Industry

The cell viability assays market is fragmented and competitive owing to the presence of various small and large market players. Some of the market players are Abcam PLC, Becton Dickinson & Company, Bio-Rad Laboratories, Biotek Instruments, Creative Bioarray, GE Healthcare, Merck KGaA, Perkin Elmer, Promega Corporation, and Thermo Fischer Scientific Inc.